DMS Propertindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? DMS Propertindo Tbk. trades at Rp202 (market cap 2.13T, 284.66M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: DMS Propertindo Tbk. is far larger — about 12.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and DMS Propertindo Tbk. is more actively traded (284.66M versus 324K). Which is the better fit depends on your goals.
| KOTA | OBAT | |
|---|---|---|
Market Cap | 2.13T | 166.01B |
Volume | 284.66M | 324K |
Lot | 2.85M | 3.24K |
Turnover | 56.57B | 77.68M |
Average Price | 198.73 | 239.75 |
Value | 56.57B | 77.68M |
Indicative Equilibrium Price | 202 | 240 |
Indicative Equilibrium Volume | 90.31K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT DMS Propertindo Tbk (the Company) was established in the Republic of Indonesia based ondeed of establishment No. 4 of Notary M. Nova Faisal, SH., M.Kn., dated January 7, 2011.
Read more on KOTA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →